PLRZ

Polyrizon Ltd. - Ordinary Shares (PLRZ)

About Polyrizon Ltd. - Ordinary Shares (PLRZ)

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Details

Daily high

$0.72

Daily low

$0.69

Price at open

$0.70

52 Week High

$1,200.00

52 Week Low

$0.55

Market cap

19,200

Dividend yield

0.00%

Volume

95,212

Avg. volume

263,446

P/E ratio

-.01

Polyrizon Ltd. - Ordinary Shares News